Blokhin Victor, Pavlova Ekaterina N, Katunina Elena A, Nodel Marina R, Kataeva Galina V, Moskalets Elina R, Pronina Tatiana S, Ugrumov Michael V
Laboratory of Neural and Neuroendocrine Regulations, Koltzov Institute of Developmental Biology of Russian Academy of Sciences, Moscow 119334, Russia.
Federal Center of Brain Research and Neurotechnologies of the Russian Federal Medical and Biological Agency, Moscow 117513, Russia.
J Clin Med. 2024 Feb 2;13(3):875. doi: 10.3390/jcm13030875.
Parkinson's disease (PD) is diagnosed by the onset of motor symptoms and treated long after its onset. Therefore, the development of the early diagnosis of PD is a priority for neurology. Advanced methodologies for this include (1) searching for patients at risk of developing prodromal PD based on premotor symptoms; (2) searching for changes in the body fluids in these patients as diagnostic biomarkers; (3) verifying the diagnosis of prodromal PD and diagnostic-value biomarkers using positron emission tomography (PET); (4) anticipating the development of motor symptoms. According to our data, the majority of patients ( = 14) at risk of developing PD selected in our previous study show pronounced interhemispheric asymmetry in the incorporation of 18F-DOPA into dopamine synthesis in the striatum. This was assessed for the caudate nucleus and putamen separately using the specific binding coefficient, asymmetry index, and putamen/caudate nucleus ratio. Interhemispheric asymmetry in the incorporation of 18F-DOPA into the striatum provides strong evidence for its dopaminergic denervation and the diagnostic value of previously identified blood biomarkers. Of the 17 patients at risk of developing prodromal PD studied using PET, 3 patients developed motor symptoms within a year. Thus, our study shows the promise of using the described methodology for the development of early diagnosis of PD.
帕金森病(PD)通过运动症状的出现来诊断,且在发病很久后才进行治疗。因此,PD的早期诊断发展是神经病学的一个优先事项。为此的先进方法包括:(1)根据运动前症状寻找有前驱期PD发病风险的患者;(2)寻找这些患者体液中的变化作为诊断生物标志物;(3)使用正电子发射断层扫描(PET)验证前驱期PD和诊断价值生物标志物的诊断;(4)预测运动症状的发展。根据我们的数据,在我们之前的研究中选择的大多数有PD发病风险的患者(n = 14)在纹状体多巴胺合成中18F-DOPA摄取方面表现出明显的半球间不对称。这分别使用特异性结合系数、不对称指数和壳核/尾状核比率对尾状核和壳核进行了评估。18F-DOPA摄取到纹状体中的半球间不对称为其多巴胺能去神经支配以及先前确定的血液生物标志物的诊断价值提供了有力证据。在使用PET研究的17例有前驱期PD发病风险的患者中,3例在一年内出现了运动症状。因此,我们的研究表明了使用所述方法进行PD早期诊断发展的前景。